Clinical Trials Directory

Trials / Terminated

TerminatedNCT03972813

Optimizing HPV Vaccine Introduction in Shanghai, China

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
1,021 (actual)
Sponsor
University of Michigan · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Within low, middle, and upper income countries, low vaccine coverage results from both obstacles to vaccine access and low confidence in vaccine programs. Thus, it is critical to determine how best to enhance trust in vaccines as increasing numbers of vaccines are recommended for use. Even though the context accompanying the initial roll-out of a vaccine can have a large impact on people's perceptions of the vaccine and the corresponding disease, it is not clear how to best introduce a vaccine to increase public confidence and enhance uptake. The US roll-out of the human papillomavirus (HPV) vaccine framed HPV as a sexually transmitted infection, which proved to be an impediment to efforts to increase vaccine uptake \>10 years after its introduction. This study will use an educational experiment, where parents of children will be exposed to information about the HPV vaccination in different ways. Parents will be introduced to the HPV vaccine through different scenarios with varying emphases (i.e., age at vaccination, types of transmission, type of cancer prevention). The aim will be to determine how the framing of the HPV vaccination across several dimensions affects short-term willingness to receive it.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBroadened information about cancersCaregivers receive information that HPV causes more than just cervical cancer.
BEHAVIORALInformation about STDsCaregivers learn that HPV is an STD.
BEHAVIORALInformation about infectious diseaseCaregivers learn that HPV is infectious (but information that it is an STD is omitted).
BEHAVIORALRecommendation for children 12 years oldCaregivers are prompted to get their child vaccinated when the child is 12 years old.
BEHAVIORALRecommendation for children 18 years oldCaregivers are prompted to get their child vaccinated when the child is 18 years old.
BEHAVIORALStandard age informationCaregivers are given information about when the HPV vaccination can be given in China, but no additional recommendations.
BEHAVIORALCervical cancerCaregivers are told that HPV causes cervical cancer.
BEHAVIORALBlank information about communicabilityCaregivers are not given any information on how HPV is spread.

Timeline

Start date
2019-05-28
Primary completion
2019-08-31
Completion
2019-08-31
First posted
2019-06-04
Last updated
2025-01-15
Results posted
2020-01-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03972813. Inclusion in this directory is not an endorsement.